Pharsight

Drugs that contain Amiodarone Hydrochloride

1. Nexterone patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6869939 BAXTER HLTHCARE Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
May, 2022

(1 year, 9 months ago)

US7635773 BAXTER HLTHCARE Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

Market Authorisation Date: 24 December, 2008

Treatment: NA

Dosage: INJECTABLE;INJECTION

More Information on Dosage

NEXTERONE family patents

Family Patents